Zobrazeno 1 - 10
of 1 496
pro vyhledávání: '"Zettl F"'
Autor:
Ma S; Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230601, China., Sandhoff R; Lipid Pathobiochemistry Group (A411), 69120 Heidelberg, Germany., Luo X; CAS Key Laboratory of Infection and Immunity, CAS Center for Excellence in Biomacromolecules, National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China., Shang F; Cellular Immunology (D110), German Cancer Research Center, 69120 Heidelberg, Germany.; Faculty of Medicine, Heidelberg University, Heidelberg, Germany., Shi Q; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China., Li Z; CAS Key Laboratory of Infection and Immunity, CAS Center for Excellence in Biomacromolecules, National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China., Wu J; Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230601, China., Ming Y; Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230601, China., Schwarz F; Core Facility Antibodies (W170), German Cancer Research Center, 69120 Heidelberg, Germany., Madi A; Immune Diversity (D150), German Cancer Research Center, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Weisshaar N; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; T Cell Metabolism (D192), German Cancer Research Center, 69120 Heidelberg, Germany., Mieg A; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; T Cell Metabolism (D192), German Cancer Research Center, 69120 Heidelberg, Germany., Hering M; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; T Cell Metabolism (D192), German Cancer Research Center, 69120 Heidelberg, Germany., Zettl F; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.; T Cell Metabolism (D192), German Cancer Research Center, 69120 Heidelberg, Germany., Yan X; Immune Diversity (D150), German Cancer Research Center, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Mohr K; T Cell Metabolism (D192), German Cancer Research Center, 69120 Heidelberg, Germany., Ten Bosch N; T Cell Metabolism (D192), German Cancer Research Center, 69120 Heidelberg, Germany., Li Z; Division of Pathogenesis of Virus Associated Tumors (F100), German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany., Poschet G; Metabolomics Core Technology Platform, Centre for Organismal Studies (COS), Heidelberg University, 69120 Heidelberg, Germany., Rodewald HR; Cellular Immunology (D110), German Cancer Research Center, 69120 Heidelberg, Germany., Papavasiliou N; Immune Diversity (D150), German Cancer Research Center, 69120 Heidelberg, Germany., Wang X; State Key Laboratory of Reproductive Medicine, Nanjing Medical University, Nanjing, China., Gao P; CAS Key Laboratory of Infection and Immunity, CAS Center for Excellence in Biomacromolecules, National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China., Cui G; Key Laboratory of Immune Response and Immunotherapy, Center for Advanced Interdisciplinary Science and Biomedicine of IHM, School of Basic Medical Sciences, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, 230601, China.; T Cell Metabolism (D192), German Cancer Research Center, 69120 Heidelberg, Germany.
Publikováno v:
Science immunology [Sci Immunol] 2024 Apr 19; Vol. 9 (94), pp. eadg8817. Date of Electronic Publication: 2024 Apr 19.
Autor:
Weisshaar N; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Ma S; Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, China., Ming Y; Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, China., Madi A; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Mieg A; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Hering M; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Zettl F; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany., Mohr K; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Heidelberg, Germany., Ten Bosch N; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Heidelberg, Germany.; Helmholtz Institute for Translational Oncology (HI-TRON)-A Helmholtz Institute of the DKFZ, Mainz, Germany., Stichling D; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Heidelberg, Germany., Buettner M; Metabolomics Core Technology Platform, Centre for Organismal Studies (COS), Heidelberg University, Heidelberg, Germany., Poschet G; Metabolomics Core Technology Platform, Centre for Organismal Studies (COS), Heidelberg University, Heidelberg, Germany., Klinke G; Metabolomics Core Technology Platform, Centre for Organismal Studies (COS), Heidelberg University, Heidelberg, Germany., Schulz M; Metabolomics Core Technology Platform, Centre for Organismal Studies (COS), Heidelberg University, Heidelberg, Germany., Kunze-Rohrbach N; Metabolomics Core Technology Platform, Centre for Organismal Studies (COS), Heidelberg University, Heidelberg, Germany., Kerber C; Tissue Bank of the German Center for Infection Research (DZIF), Partner Site Heidelberg, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Klein IM; Tissue Bank of the German Center for Infection Research (DZIF), Partner Site Heidelberg, Institute of Pathology, Heidelberg University Hospital, Heidelberg, Germany., Wu J; Institute of Health and Medicine, Hefei Comprehensive National Science Center, Hefei, China. jingxia.wu@ihm.ac.cn., Wang X; State Key Laboratory of Reproductive Medicine and Offspring Health, Nanjing Medical University, Nanjing, China. xiwang@njmu.edu.cn., Cui G; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Heidelberg, Germany. g.cui@dkfz.de.; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany. g.cui@dkfz.de.; Helmholtz Institute for Translational Oncology (HI-TRON)-A Helmholtz Institute of the DKFZ, Mainz, Germany. g.cui@dkfz.de.
Publikováno v:
Nature immunology [Nat Immunol] 2023 Nov; Vol. 24 (11), pp. 1921-1932. Date of Electronic Publication: 2023 Oct 09.
Autor:
Madi A; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120, Heidelberg, Germany., Wu J; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Ma S; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Weisshaar N; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Mieg A; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120, Heidelberg, Germany., Hering M; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120, Heidelberg, Germany., Ming Y; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Zettl F; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120, Heidelberg, Germany., Mohr K; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Ten Bosch N; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Helmholtz Institute for Translational Oncology (HI-TRON), Mainz, Germany., Schlimbach T; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Hertel F; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany., Cui G; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120, Heidelberg, Germany.; Helmholtz Institute for Translational Oncology (HI-TRON), Mainz, Germany.
Publikováno v:
European journal of immunology [Eur J Immunol] 2023 Jan; Vol. 53 (1), pp. e2149400. Date of Electronic Publication: 2022 Nov 04.
Autor:
Braulke F; Department of Hematology and Medical Oncology, University Medical Center Goettingen, Germany; current address: Comprehensive Cancer Center, University Medical Center Goettingen, Germany., Zettl F; Department of Hematology and Oncology, Klinikum Traunstein, Germany., Ziepert M; Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Germany., Viardot A; Department of Internal Medicine III, University Hospital Ulm, Germany., Kahl C; Department of Hematology, Oncology and Palliative Care, Klinikum Magdeburg, Germany.; Department Internal Medicine, Clinic III - Hematology, Oncology and Palliative Care, Rostock University Medical Center, Rostock, Germany., Prange-Krex G; Onkologische Gemeinschaftspraxis, Dresden, Germany., Korfel A; Department of Hematology and Oncology, Charité University Hospital Berlin, Germany; current address: Medical Department Oncology, Lilly GmbH, Bad Homburg, Germany., Dreyling M; Department of Medicine III, University Hospital Ludwig Maximilians University, Munich, Germany., Bott A; Department of Hematology and Medical Oncology, Paracelsus Medical University, Nuermberg, Germany., Wedding U; Department of Palliative Care, Jena University Hospital, Jena, Germany., Reichert D; Outpatient Center for Oncology, Westerstede, Germany., de Wit M; Klinik für Innere Medizin - Hämatologie, Onkologie und Palliativmedizin, Vivantes Klinikum Neukölln, Berlin, Germany., Hartmann F; Department of Hematology and Oncology, Klinikum Lippe, Lemgo, Germany., Poeschel V; Medicine 1 (Oncology, Hematology, Clinical Immunology, and Rheumatology), Saarland University Medical School, Homburg/Saar, Germany., Schmitz N; Medical Department A, Hematology and Oncology, University Medicine of Muenster, Germany., Witzens-Harig M; Department of Hematology, Oncology and Rheumatology, University Hospital Heidelberg, Germany., Klapper W; Department of Pathology, Hematopathology Section and Lymph Node Registry Kiel, University Hospital Schleswig-Holstein, Kiel, Germany., Rosenwald A; Institute of Pathology, Comprehensive Cancer Center Mainfranken, University of Würzburg, Germany., Wulf G; Department of Hematology and Medical Oncology, University Medical Center Goettingen, Germany; current address: Comprehensive Cancer Center, University Medical Center Goettingen, Germany., Altmann B; Institute for Medical Informatics, Statistics and Epidemiology (IMISE), University of Leipzig, Germany., Trümper L; Department of Hematology and Medical Oncology, University Medical Center Goettingen, Germany; current address: Comprehensive Cancer Center, University Medical Center Goettingen, Germany.
Publikováno v:
HemaSphere [Hemasphere] 2022 Dec 01; Vol. 6 (12), pp. e808. Date of Electronic Publication: 2022 Dec 01 (Print Publication: 2022).
Autor:
Zettl F; Department of Hematology, Oncology and Palliative Care, Klinikum Traunstein, Traunstein, Germany. florian.zettl@kliniken-sob.de., Ziepert M; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Altmann B; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Zeynalova S; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Held G; Department of Internal Medicine, University Hospital Saarland, Homburg, Germany., Pöschel V; Department of Internal Medicine, University Hospital Saarland, Homburg, Germany., Hohloch K; Department of Hematology and Medical Oncology, Georg August University Göttingen, Göttingen, Germany.; Hematology and Oncology, Kantonsspital Graubünden, Chur, Switzerland., Wulf GG; Department of Hematology and Medical Oncology, Georg August University Göttingen, Göttingen, Germany., Glass B; Department of Hematology, Oncology, and Tumor Immunology, Helios Klinikum Berlin-Buch, Berlin, Germany., Schmitz N; Department of Internal Medicine A, University of Münster, Münster, Germany., Loeffler M; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany., Trümper L; Department of Hematology and Medical Oncology, Georg August University Göttingen, Göttingen, Germany.
Publikováno v:
Annals of hematology [Ann Hematol] 2021 Apr; Vol. 100 (4), pp. 1031-1038. Date of Electronic Publication: 2020 Nov 26.
Autor:
Weisshaar N; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany., Wu J; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Ming Y; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Madi A; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany., Hotz-Wagenblatt A; Core Facility Omics IT and Data Management, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Ma S; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Mieg A; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany., Hering M; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany., Zettl F; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany., Mohr K; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Schlimbach T; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Ten Bosch N; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Hertel F; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Müller L; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Byren H; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Wang M; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Borgers H; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Munz M; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Schmitt L; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., van der Hoeven F; Transgenic Service (W450), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Kloz U; Transgenic Service (W450), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Carretero R; DKFZ-Bayer Immunotherapeutic Lab, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Schleußner N; Cancer Progression and Metastasis (A013), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Department of General, Visceral and Transplantation Surgery, University Hospital Heidelberg, University Heidelberg, 69120 Heidelberg, Germany., Jackstadt RF; Cancer Progression and Metastasis (A013), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Hofmann I; Division of Vascular Oncology and Metastasis (A190), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Core Facility Antibodies (W170), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Cui G; T Cell Metabolism Group (D192), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120 Heidelberg, Germany.; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany.; Helmholtz Institute for Translational Oncology (HI-TRON), 55131 Mainz, Germany.
Publikováno v:
Science immunology [Sci Immunol] 2022 May 27; Vol. 7 (71), pp. eabh1873. Date of Electronic Publication: 2022 May 27.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
García-Nicolás O; Institute of Virology and Immunology (IVI), Bern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland., V'kovski P; Institute of Virology and Immunology (IVI), Bern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland., Zettl F; Institute of Virology and Immunology (IVI), Bern, Switzerland., Zimmer G; Institute of Virology and Immunology (IVI), Bern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland., Thiel V; Institute of Virology and Immunology (IVI), Bern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland., Summerfield A; Institute of Virology and Immunology (IVI), Bern, Switzerland.; Department of Infectious Diseases and Pathobiology, Vetsuisse Faculty, University of Bern, Bern, Switzerland.
Publikováno v:
Frontiers in cellular and infection microbiology [Front Cell Infect Microbiol] 2021 Apr 12; Vol. 11, pp. 644574. Date of Electronic Publication: 2021 Apr 12 (Print Publication: 2021).
Autor:
Morschhauser F; Hôpital Claude Huriez, Centre Hospitalier Regional Universitaire, Lille, France., Bouabdallah K; Hopital Haut-Levêque, Centre Hospitalier Regional Universitaire de Bordeaux, Pessac, France., Stilgenbauer S; Internal Medicine III, Ulm University, Ulm, Germany., Thieblemont C; Hemato-Oncology Department, Hôpital Saint-Louis and Diderot University, Paris, France., de Guibert S; Hôpital de Pontchaillou, Rennes, France., Zettl F; Universitätsmedizin Göttingen, Göttingen, Germany., Gelbert LM; LMG PharmaTech, LLC., Indianapolis, Indiana, USA., Turner KP; Eli Lilly and Company, Indianapolis, Indiana, USA., Prasad Kambhampati SR; Eli Lilly and Company, Indianapolis, Indiana, USA., Li L; Eli Lilly and Company, Indianapolis, Indiana, USA., Li LQ; Eli Lilly and Company, Indianapolis, Indiana, USA., Buchanan S; Eli Lilly and Company, Indianapolis, Indiana, USA., Barriga S; Eli Lilly and Company, Indianapolis, Indiana, USA., Bear MM; Eli Lilly and Company, Indianapolis, Indiana, USA., Wilhelm M; Klinikum Nürnberg Nord, Nürnberg, Germany., Hess G; Universitätsmedizin Mainz, Mainz, Germany.
Publikováno v:
Haematologica [Haematologica] 2021 Mar 01; Vol. 106 (3), pp. 859-862. Date of Electronic Publication: 2021 Mar 01.
Autor:
Shen, Jialiang1 (AUTHOR), Noh, Byung‐Il1 (AUTHOR), Chen, Pengyu1 (AUTHOR), Dai, Siyuan1 (AUTHOR) sdai@auburn.edu
Publikováno v:
Small Science. Nov2024, Vol. 4 Issue 11, p1-17. 17p.